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ABSTRACT
Background At the request of the Head and Neck Cancers Advisory Committee of Ontario Health (Cancer Care 
Ontario), a working group and expert panel of clinicians with expertise in the management of head-and-neck can-
cer developed the present guideline. The purpose of the guideline is to provide advice about the organization and 
delivery of health care services for adult patients with head-and-neck cancer.
Methods This document updates the recommendations published in the Ontario Health (Cancer Care Ontario) 
2009 organizational guideline The Management of Head and Neck Cancer in Ontario. The guideline development 
methods included an updated literature search, internal review by content and methodology experts, and external 
review by relevant health care providers and potential users.
Results To ensure that all patients have access to the highest standard of care available in Ontario, the guideline 
establishes the minimum requirements to maintain a head-and-neck disease site program. Recommendations are 
made about the membership of core and extended provider teams, minimum skill sets and experience of practi-
tioners, cancer centre–specific and practitioner-specific volumes, multidisciplinary care requirements, and unique 
infrastructure demands.
Conclusions The recommendations contained in this document offer guidance for clinicians and institutions 
providing care for patients with head-and-neck cancer in Ontario, and for policymakers and other stakeholders 
involved in the delivery of health care services for head-and-neck cancer.
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INTRODUCTION
The purpose of this guideline is to provide advice about the 
organization and delivery of health care services for adult 
patients with head-and-neck cancer (not including thyroid 
cancer). The recommendations establish the minimum 
requirements to maintain a head-and-neck disease site 
program. The recommendations are intended to ensure 
that the proper infrastructure is in place and that medical, 
nursing, allied health professional, and support staff are 
experienced and properly trained. To ensure that all pa-
tients have access to the highest standard of care available 
in Ontario, the recommendations establish standards for 
minimum new-patient volumes for regional cancer centre 
disease site groups.
ORGANIZATIONAL GUIDANCE FOR HEAD-AND-NECK CANCER CARE IN ONTARIO, Irish et al.
e116 Current Oncology, Vol. 27, No. 2, April 2020 © 2020 Multimed Inc.
METHODS
This report updates the organizational guidance portion 
of the 2009 document The Management of Head and Neck 
Cancer in Ontario1. A formal review of the guideline to 
determine the continued relevance of the original rec-
ommendations and an updated literature search were 
undertaken in 2017. Little new evidence emerged. A working 
group was formed to address changes in the organization 
and delivery of care to patients with head-and-neck cancer. 
The recommendations are presented below, with additions 
and modifications to the original version labelled as “new 
2019” or “revised 2019.”
Research Questions
 n What minimum requirements are necessary for the 
organization and delivery of multidisciplinary care to 
patients with head-and-neck malignancies, including 
advanced salivary and skin cancers, but not thyroid 
cancer? Areas of interest include health care teams 
and unique infrastructure.
 n What are the recommended staff requirements and 
expertise required by medical, surgical, nursing, and 
allied health care professionals to provide optimal care 
for these patients with head-and-neck cancer? Areas 
of interest include minimum volumes and training to 
optimize patient outcomes.
Target Population
The population targeted in this guideline are adult pa-
tients who present with symptoms of, or who have been 
diagnosed with, head-and-neck malignancies, including 
advanced salivary and skin cancers, but not thyroid cancer.
Intended Users
This document is intended for administrators responsible 
for maintaining, developing, and implementing head-
and-neck cancer programs, and for oncology health care 
professionals who, during the full continuum of care from 
diagnosis to post-treatment follow-up and rehabilitation, 
interact with patients who have head-and-neck cancer.
Internal and External Review
For the internal review, an expert panel of clinical con-
tent experts reviewed the draft document and provided 
feedback. Health care practitioners with expertise in the 
guideline topic were invited to comment. Those individ-
uals were drawn from the Ontario Head and Neck Cancers 
Advisory Committee, the co-authors of the previous version 
of this guideline, the database of Ontario cancer care prac-
titioners maintained by the Program in Evidence-Based 
Care (pebc), and recommendations by working group 
members. Invitations were extended to 26 people, and 14 
agreed to participate.
External review involved using professional consul-
tation to solicit feedback from content experts about the 
approved draft guideline. Relevant care providers and 
other potential users of the guideline were contacted and 
invited to provide feedback about the guideline recommen-
dations through a brief online survey. That consultation 
was intended to facilitate the dissemination of the final 
guidance report to Ontario practitioners.
On 16 November 2018, the document was dissemin-
ated to 175 health care practitioners; the survey closed on 
14 December 2018. Practitioners with relevant expertise 
were identified in the pebc database of Ontario cancer care 
practitioners, and other relevant contacts were provided 
by the Ontario Society of Oral Maxillofacial Surgeons and 
the Royal College of Dental Surgeons of Ontario. Lists of 
speech–language pathologists and dietitians practising in 
Ontario were provided by an expert panel member.
Results of the two sources of feedback can be found in 
the full guideline report on the Ontario Health (Cancer Care 




Multidisciplinary Care by Core Team (New 2019)
 n Given the complexity of the disease and its associated 
morbidities, all adult patients who present with symp-
toms of, or who have been diagnosed with, head-and-
neck cancer should be seen and cared for by a Core 
Head and Neck Cancer Multidisciplinary Team before 
any treatment is provided.
Core Team Membership (Revised 2019)
 n The Core Team is defined as the group of clinicians 
who see most new patients with head-and-neck cancer 
and who are responsible for the assessment, treatment, 
planning, management, survivorship, and rehabilita-
tion of those patients.
 n The care of patients with head-and-neck cancer should 
be coordinated between the members of the Core Team 
to ensure optimally effective and safe care.
 n During the diagnosis, management, and follow-up 
process, each patient with head-and-neck cancer will 
have a clearly identified most responsible physician 
(mrp). The mrp refers to the physician who has overall 
responsibility for directing and coordinating the head-
and-neck cancer care of an individual patient and the 
management of their case at a specific point in time. 
The mrp will be responsible for handover of care during 
periods of absence or transition of care to a different 
mrp or between treatment modalities.
 n The multidisciplinary team should comprise:
 n Surgical oncologist with experience managing the 
entire scope of head-and-neck disease (early- to 
late-stage cases)
 n Radiation oncologist
 n Medical oncologist
 n Pathologist with expertise in both histopathology 
and cytopathology
 n Dentist with expertise in dental oncology
 n Clinical nurse specialist or nurse practitioner, 
or both
 n Specialized oncology registered nurse (inpatient 
and ambulatory registered nurses)
 n Medical imaging physician
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 n Speech–language pathologist
 n Registered dietitian
 n Social worker
 n Primary care physician
The primary care physician is not usually involved 
in the day-to-day treatment of the patient with 
head-and-neck cancer, but plays an important role 
in post-treatment supportive care and is respon-
sible for the ongoing overall health of the patient.
Based on circumstances, some primary care 
physicians might be actively involved in the acute 
care of patients with head-and-neck cancer, espe-
cially with regard to advocacy and coordination of 
supportive care. Such involvement is encouraged.
Extended Team Membership (Revised 2019)
 n The Extended Team will be called upon by the Core 
Team to facilitate treatment, planning, management, 
survivorship, and rehabilitation of the patient. Mem-
bers of the Extended Team provide more episodic care 
and are not responsible for seeing most new patients.
 n Members of the Extended Team must have training 
or experience managing patients with head-and-neck 
cancers. The team comprises:
 n Anesthesiologist with expertise in airway man-
agement
 n Audiologist
 n Dental technicians and hygienists
 n Health care providers with expertise in gastrosto-
my creation, feeding tube placement, and support 
for patients who require tube feeding
 n Home care team
 n Hyperbaric medicine
 n Interventional radiologist
 n Mental health providers, including psychiatrist 
or psychologist
 n Occupational therapist
 n Ophthalmologist
 n Oral and maxillofacial surgeon
 n Pain management specialist
 n Palliative care specialist
 n Physiotherapist
 n Prosthodontist or prosthetic anaplastologist
 n Radiation physicist
 n Medical radiation technologist (radiation therapist)
 n Respiratory therapist
Minimal Skill Set and Experience for Treating  
Head-and-Neck Carcinomas
Surgical Oncologist (Revised 2019)
 n A head-and-neck surgical oncologist must have exper-
tise in and the ability to
 n investigate, diagnose, stage, restage, and treat 
patients with head-and-neck cancer.
 n provide diagnostic testing that should include
 n imaging such as ultrasonography, contrast- 
enhanced computed tomography, magnetic 
resonance imaging, and positron-emission 
tomography;
 n the performance of point-of-care fine-needle 
aspiration biopsy; and
 n direct tissue biopsy, with access to frozen sec-
tion pathologic examination.
 n perform staging examinations, including
 n flexible nasopharyngoscopy in an ambulatory 
care clinic,
 n panendoscopy and examination under general 
anesthesia, and
 n open neck biopsy.
 n perform essential procedures to manage the up-
per aerodigestive tract and support patients with 
head-and-neck cancer:
 n Tracheotomy
 n Rigid laryngoscopy
 n Rigid esophagoscopy
 n Nasogastric and percutaneous feeding tube 
insertions (have the necessary access)
 n perform extirpative surgical procedures for the 
treatment of skin, salivary gland, sinus or skull 
base, oral cavity, laryngopharyngeal, and thy-
roid cancers, and for the management of cervical 
lymph nodes.
 n provide minimally invasive oncologic procedures 
such as endoscopic surgery or transoral robotic 
surgery.
 n perform reconstructive surgical procedures that 
include
 n nerve grafting (such as facial nerve);
 n skin and mucosal grafting; and
 n local, regional, and pedicle flap reconstruction.
 n be a member of a reconstructive team for which 
microvascular reconstruction is readily available.
 n Surgeons must have completed advanced fellowship 
training in head-and-neck surgical oncology.
 n Prerequisite to fellowship requires that candidates
 n attain the Royal College of Physicians and Sur-
geons of Canada (rcpsc) Surgical Foundations 
examination (or equivalent).
 n maintain a surgical case log to demonstrate suf-
ficient competency relevant to the treatment of 
patients with head-and-neck cancer.
 n successfully complete a rcpsc-approved surgical 
residency (or equivalent).
 n Advanced fellowship training must
 n be of at least 1 years’ duration.
 n maintain a surgical case log to demonstrate suffi-
cient proficiency in the foregoing list with respect 
to “expertise and ability.”
Note: Advanced training is defined as an Advanced 
Training in Head and Neck Oncologic Surgery Fellowship 
through the Canadian Association of Head and Neck Surgi-
cal Oncology (https://cahnso.com/) or the American Head 
and Neck Society (https://www.ahns.info/).
Head-and-Neck Microvascular Reconstructive 
Surgeon (Revised 2019)
 n The head-and-neck microvascular reconstructive 
surgeon is an integral member of the head-and-neck 
oncology team.
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 n Advanced fellowship training in head-and-neck mi-
crovascular surgery is required.
Note: An individual surgeon may meet the training 
standards and criteria as both a head-and-neck surgical 
oncologist and a microvascular reconstructive surgeon.
Radiation Oncologist
 n Has completed a degree in medicine (or equivalent), 
including the rcpsc Specialist Certificate in Radiation 
Oncology (or equivalent).
 n Has enhanced knowledge and skill in the treatment 
of patients with head-and-neck cancer, acquired from 
either a formal clinical fellowship or significant clini-
cal training in head-and-neck cancer treatment at an 
expert centre during radiation.
Medical Oncologist
 n Has completed a degree in medicine (or equivalent), 
including the rcpsc Specialist Certificate in Internal 
Medicine (or equivalent), as well as the rcpsc Cer-
tificate of Special Competence in Medical Oncology 
(or equivalent).
 n Has enhanced knowledge and skill in the treatment 
of patients with head-and-neck cancer, acquired 
from either a formal clinical fellowship or significant 
clinical training in head-and-neck cancer treatment 
at an expert centre during medical oncology residency 
or fellowship.
Dentist with Expertise in Dental Oncology
 n Has completed a university-based degree in dentistry 
and fulfilled the requirements of the Royal College of 
Dental Surgeons of Ontario, and completed a 1-year 
hospital residency program that includes training 
and experience with patients who have head-and-
neck cancer, or an oral pathology or oral medicine 
residency program approved by the Commission on 
Dental Accreditation of Canada.
Pathologist
 n Has completed a degree in medicine (or equivalent), 
including the rcpsc Certificate of Special Competence 
in Anatomical Pathology.
 n Has enhanced knowledge and skill in the pathology of 
head-and-neck malignancies, acquired from either a 
formal fellowship or significant training in head-and-
neck cancer at an expert centre.
Registered Nurse
 n All entry-to-practice nurses shall have a Bachelor’s 
degree in nursing and be registered with the College of 
Nurses of Ontario. Ideally, all nurses will hold a Certified 
in Oncology Nursing (Canada) credential and member-
ship in the Canadian Association of Nurses in Oncology.
Generalized and Specialized Oncology Nurses
 n Generalized and specialized oncology nurses have 
enhanced specialty knowledge and skill, and practice 
in an environment in which most individuals have a 
diagnosis of cancer or are at risk of developing cancer.
 n The registered nurse is able to
 n conduct a comprehensive health assessment, en-
gage in supportive and therapeutic relationships 
with patients and families, and manage cancer 
symptoms and treatment side effects;
 n provide teaching, coaching, psychosocial–spiritual 
support, and counselling across the continuum;
 n facilitate continuity of care and system navigation, 
self-determination, and informed decision-making 
for the individual or family; and
 n integrate best-practice or evidence-based know-
ledge in the care of patients and families2–4.
Ideally, a registered nurse working with this 
patient population will have general oncology 
experience or be mentored to develop the skills 
to work with the patient population.
 n Specialized oncology nurses should be aligned and 
integral to the care of this patient population in both 
inpatient and outpatient or ambulatory care settings.
 n In ambulatory care, a primary registered nurse, case 
management model, or head-and-neck site–specific 
model should be established such that patients and 
families will receive consistent care across the trajec-
tory (diagnosis, treatment, and survivorship or palli-
ation) and care settings (new-patient clinics, reviews, 
and follow-up) for assessment, treatment planning, 
symptom management, psychosocial support, and 
long-term follow-up.
Advanced Practice Nurse (Clinical Nurse Specialist 
or Nurse Practitioner)
 n Advanced practice nurses should be aligned to any or 
all of complex, specialized, or high-risk patient popula-
tions. The advanced practice nurse roles are designed 
to address and meet the needs of individuals, families, 
and groups of patients, and to have an impact at the 
patient, organization, and system levels5.
 n The nurse practitioner should possess advanced 
knowledge and skill to autonomously diagnose, order, 
and interpret diagnostic tests; to prescribe treatment 
(including drugs); and to perform specific procedures 
within their legislated scope of practice6. The nurse 
practitioner should support patients receiving con-
current treatment.
 n The clinical nurse specialist has a Doctoral or Mas-
ter’s degree in nursing, with knowledge and expertise 
in an area of cancer nursing. The breadth and depth 
of knowledge is greater than that for the specialized 
oncology nurse. The clinical nurse specialist functions 
in the domains of direct clinical care, education, re-
search, organizational leadership, and professional 
development. The nurse practitioner, in addition to the 
foregoing, has completed an approved post-Master’s 
nurse practitioner specialty certificate, is registered 
in the “extended class,” and has an expanded scope 
of practice that includes ordering diagnostics, diag-
nosing, prescribing, treating, referring, and admitting 
or discharging. The advanced practice nurse should 
have prior oncology experience and expertise, but 
might require role mentoring to develop specific 
oncology expertise5,7,8.
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Medical Imaging Physician
 n The medical imaging physician has completed a de-
gree in medicine (or equivalent), is a member of the 
College of Physicians and Surgeons of Ontario, and 
has completed the rcpsc 5-year residency program 
and received a Certificate of Special Competence in 
Diagnostic Radiology.
 n The residency should be followed by 1 or more years of 
fellowship training in a subspecialty discipline.
Speech–Language Pathologist
 n The speech–language pathologist has a Master’s degree 
(or equivalent) in speech pathology, is a registered mem-
ber of the College of Audiologists and Speech–Language 
Pathologists of Ontario, and is an independent autho-
rizer with the Assistive Devices Program. Knowledge 
and expertise in clinical swallowing assessment and 
therapy, video fluoroscopic swallowing assessment, 
and the management of patients with tracheotomies 
is required. If required to do voice restoration work 
for patients who have undergone laryngectomy, the 
speech pathologist should be approved for delegat-
ed controlled acts and have specialized training in 
tracheoesophageal puncture.
Registered Dietitian
 n The registered dietitian has a Bachelor’s degree in hu-
man nutrition and dietetics from a university program 
that has been accredited by the Partnership for Dietetic 
Education and Practice, and a post-degree supervised 
practicum program accredited by the Partnership for 
Dietetic Education and Practice.
 n Registration with the College of Dietitians of Ontario 
is required; membership with the Dietitians of Canada 
is recommended.
 n Hospital or patient care experience, or oncology ex-
pertise (or both) is recommended.
 n Registered dietitians complete detailed clinical nutri-
tion assessments, develop individualized patient care 
goals and a nutrition care plan, and provide ongoing 
follow-up through the continuum of care.
 n The registered dietitian has experience and training 
in nutrition support, with knowledge and expertise 
in swallowing function and dysphagia assessment 
and treatment.
Social Worker
 n The social worker has a Master’s degree in social work, 
registration with the Ontario College of Social Workers 
and Social Service Workers, and hospital or patient care 
experience as well as oncology expertise.
 n Through a comprehensive psychosocial assessment, 
social workers should have experience in understand-
ing and treating the social, psychological, emotional, 
spiritual, quality-of-life, and functional aspects of 
cancer, working with patients and their caregivers 
alike across the cancer care continuum.
 n Affiliation and membership with professional oncol-
ogy social work organizations such as the Canadian 
Association of Psychosocial Oncology and the Ontar-
io Association of Social Workers are recommended.
Primary Care Physician
 n The primary care physician has completed a degree 
in medicine (or equivalent), ideally including a Col-
lege of Family Physicians of Canada Certificate in 
Family Medicine.
Oral and Maxillofacial Surgeon (New 2019)
 n The oral and maxillofacial surgeon must have
 n expertise in dental rehabilitation and implant re-
habilitation to support maxillofacial prostheses.
 n a degree in dentistry at an accredited dental 
school, followed by postgraduate residency train-
ing and successful completion of specialty ex-
aminations administered by the National Dental 
Examining Board of Canada of the Royal College 
of Dentists of Canada.
 n a frcd(c) Certificate in Oral and Maxillofacial 
Surgery, Fellowship Training Certif icate (or 
equivalent).
 n Royal College of Dental Surgeons of Ontario spe-
cialty certification as an oral and maxillofacial 
surgeon.
Volumes
Cancer Centre–Specific and Practitioner-Specific 
Volumes (Revised 2019)
 n Innovative collaborations between high-volume and 
low-volume centres or regions should be expanded 
and defined to maintain the high quality of care being 
provided to this group of patients. Such collaborations 
include virtual multidisciplinary case conferencing 
options and joint care planning with regional care- 
delivery models.
 n The development of small-volume, non-multidisciplinary 
treatment programs for patients with head-and-neck 
cancer should be strongly discouraged.
The human resources and proficiency volumes out-
lined in the subsections that follow are drawn from the 
recommendations in the original guideline and from the 
oh(cco) Head and Neck Standards—Designated Centre Re-
quirements, which were developed by a multidisciplinary 
steering committee in 2014 to operationalize the original 
recommendations. No data are available in Ontario or 
elsewhere to directly inform minimum volume thresholds 
for surgeons, medical oncologists, or radiation oncologists 
to ensure high-quality care. Additionally, no data or exist-
ing clinical practice guidelines in Ontario or elsewhere 
are available to directly inform the minimum volumes for 
specialized oncology nurses, advanced practice nurses, 
speech–language pathologists, registered dietitians, or 
social workers. The revised guideline working group be-
lieves that the volumes set out here are reasonable goals 
in Ontario.
Recommended Minimum Volumes: Surgery
 n Each centre offering surgery should have a minimum 
of 80 head-and-neck surgeries per year and a min-
imum of 2 head-and-neck surgical oncologists.
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 n If reconstructive microsurgeries are performed at a 
centre, either by a head-and-neck surgical oncologist 
or a plastic surgeon, the surgeon should perform a min-
imum of 20 reconstructive microvascular procedures 
each year (the 20 reconstructive surgeries are included 
in the 80-case volume).
 n Generally, head-and-neck cancer surgery cases should 
be consolidated to a small number of specialized sur-
geons to ensure high quality of care.
Recommended Minimum Volumes:  
Radiation Oncology
 n Optimally, all centres offering radiation to patients 
with head-and-neck cancer should treat a minimum 
of 100 patients per year and have a minimum of 
2 radiation oncologists with expertise in head-and- 
neck cancer.
 n However, radiation may be provided in centres that 
treat a minimum of 50 patients per year if they meet 
all the requirements for radiation services (including 
2 radiation oncologists on site and necessary human 
and physical resources) to accommodate patients who 
live remotely. In that situation, it is expected that, to 
optimize experience and treatment, both radiation 
oncologists will be involved in the planning and man-
agement of all patients.
 n Generally, head-and-neck cancer cases should be con-
solidated to a small number of specialized radiation 
oncologists to ensure high quality of care.
Recommended Minimum Volumes:  
Systemic Therapy
 n Volumes for systemic therapy will generally be dictated 
by radiation oncology volumes, because chemotherapy 
is usually given concurrently with radiation.
 n Chemotherapy delivered concurrently with radiation 
should be delivered only in centres in which the radi-
ation is being given.
 n There should be a minimum of 2 medical oncologists 
with expertise in head-and-neck cancers at that centre.
 n There is no volume requirement for patients receiving 
palliative chemotherapy. Palliative chemotherapy 
can be delivered at any regional systemic treatment 
program site.
Recommended Minimum Volumes:  
Allied Health Professionals
 n Specialized oncology nurse
 n 1.0 full-time equivalent (fte) per 100 patients with 
head-and-neck cancer
 n Advanced practice nurse
 n 1.0 fte per head-and-neck site group (especially 
with larger site groups seeing more than 200 pa-
tients in consultation per year or shared across 
another site group)
 n Speech–language pathologist
 n 1.0 fte per 150 patients with head-and-neck cancer
 n Registered dietitian
 n 1.0 fte per 150 patients with head-and-neck cancer
 n Social worker
 n 1.0 fte per 150 patients with head-and-neck cancer
Multidisciplinary Care Requirements (New 2019)
 n Head-and-neck centres will provide surgery, radiation, 
and systemic therapy.
 n All patients with head-and-neck cancer require a multi-
disciplinary assessment by a head-and-neck surgical 
oncologist and a radiation oncologist with expertise 
in head-and-neck oncologic cases at a minimum, and 
should receive assessment by medical oncology as 
needed. See the multidisciplinary cancer conference 
guidance and information at https://www.cancercare 
ontario.ca/en/guidelines-advice/types-of-cancer/286.
 n Where geography makes it difficult for patients to 
travel to be seen in person, assessment must include 
examination by an otolaryngologist or head-and-neck 
surgeon who is available in the local community. In 
addition, patients must be reviewed at a multidisci-
plinary case conference with a head-and-neck surgical 
oncologist in attendance or by virtual review of the 
images and clinical examination by a head-and-neck 
surgical oncologist.
 n To allow care closer to home, radiation may be provid-
ed in centres not offering surgery if they meet all the 
requirements for radiation services and are partnered 
with a head-and-neck centre.
 n A “2-site” model is divided only by discipline and does 
not refer to meeting volumes in one discipline (for 
example, surgery or radiation) by spreading it across 
2 hospitals. Each site is responsible for ensuring that 
patients have access to all of the required human and 
physical resources.
Unique Infrastructure Requirements (Revised 2019)
 n The head-and-neck oncologic program must function 
within an acute-care hospital and be affiliated with 
a regional cancer program. The program must have 
access to regular ambulatory care facilities, diagnostic 
and staging expertise and equipment, inpatient re-
sources, and operating room access for cancer surgery.
Note: These requirements are unique to the treatment of 
head-and-neck cancer and are beyond those requirements 
that would typically be found in such settings.
Multidisciplinary Ambulatory Care Clinic 
(New 2019)
 n Timely access to allied health professionals (speech–
language pathology, audiology, social work, nutrition, 
oncology nursing)
 n Access to audiology services and assessment of middle 
and inner ear function
Perioperative
 n Infrastructure for microvascular, laser, and minimally 
invasive surgery
 n Rapid access to neurosurgery, thoracic surgery, and 
vascular surgery intraoperative support
 n Perioperative monitoring (level iii or greater)—for ex-
ample, specialized surgical nursing units with avail-
able 24-hour care, expertise in airway management, 
and free flap monitoring
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 n Clinic equipment for nasopharyngoscopy and image 
capture
 n Access to rigid laryngoscopy, esophagoscopy, bron-
choscopy
 n Access to surgical pathology and frozen section
Medical Oncology
 n Ambulatory chemotherapy unit and oncology phar-
macy support
 n Access to inpatient and ambulatory services, including 
ability to administer chemotherapy
Radiation Oncology
 n Radiation treatment facility including these capabilities:
 n Linear accelerator–based external-beam radi-
ation treatment with multileaf collimation and 
intensity-modulated radiation therapy or volu-
metric-modulated arc therapy
 n Computed tomography simulation (with intrave-
nous contrast available) and custom immobilization
 n Daily image-guided radiation therapy
 n Medical dosimetry and physics support for plan 
development and quality assurance meeting or 
exceeding provincial and national standards
 n Resources for staff and infrastructure to support 
the acute and long-term patient experience, in-
cluding access to all multidisciplinary programs
Diagnostic Imaging (New 2019)
 n Access to positron-emission tomography imaging for 
insured indications (for current indications see: https://
www.petscansontario.ca/cms/One.aspx?portalId= 
69866&pageId=69897#)
 n Ultrasound with access to point-of-care needle biopsy
 n Ancillary testing as required (for example, generalized 
metastatic survey, bone scan, abdominal or pelvic 
computed tomography, brain imaging)
Molecular Pathology and Testing for Human 
Papillomavirus (New 2019)
 n Human papillomavirus status of squamous cell carci-
nomas of oropharynx
 n Epstein–Barr virus status of keratinizing and nonke-
ratinizing carcinomas of the nasopharynx
Nursing
 n Access to interventional radiology for insertion of 
percutaneous endoscopic gastroscopy tubes
 n Feeding pumps for inpatient and ambulatory settings
 n Access to and support from vascular access programs
 n Access to space to see patients collaboratively and 
independently from other team members, including 
ability to assess drop-in patients and to manage after- 
hours care
 n Triage line access to support patients outside of clinic 
hours
 n Access to acute-care services to manage acute patients 
and systems to respond to medical emergencies
 n Drop-in clinics (for example, radiation nursing clinic, 
urgent-care clinics)
 n Access to a nurse practitioner for patients receiving 
concurrent treatment
Speech–Language Pathology
 n Specialized equipment for speech rehabilitation 
(post-laryngectomy)
 n Availability of and access to radiology for completion of 
modified barium swallows and equipment to support 
the analysis of swallowing function
 n Access to space to see patients collaboratively and 
independently, including ability to assess drop-in 
patients
Nutrition
 n Access to interventional radiology for insertion of a 
radiology-inserted gastrostomy or access to the endos-
copy suite for percutaneous endoscopic gastroscopy
 n Access to enteral feeding supplies for the delivery of 
enteral nutrition
Dentistry (New 2019)
 n Capacity to support institutional volumes
 n Intraoral and extraoral (panoramic) or cone-beam 
computed tomography imaging
 n Instrumentation, supplies, and staffing to quickly and 
efficiently eliminate sources of infection
 n Instrumentation, supplies, and staffing to provide oral 
surgical, operative, prosthetic or maxillofacial pros-
thetic, preventive, and follow-up dental care
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